UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma

British journal of cancer, 2009-12, Vol.101 (12), p.2005-2014

2009

Volltextzugriff (PDF)

9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers

Annals of oncology, 2018-10, Vol.29, p.viii9-viii9

2018

Volltextzugriff (PDF)

Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis

British journal of cancer, 2008-03, Vol.98 (5), p.941-949

2008

Volltextzugriff (PDF)

Prognostic impact of FAS CD95 APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression

British journal of cancer, 2005-09, Vol.93 (5), p.544-551

2005

Volltextzugriff (PDF)

2536 Treatment sequence using new antiandrogens in castration resistant prostate cancer: A retrospective study

European journal of cancer (1990), 2015-09, Vol.51, p.S487-S487

2015

Volltextzugriff (PDF)

Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients

British journal of cancer, 2004-01, Vol.90 (1), p.200-205

2004

Volltextzugriff (PDF)

Absence of Bcl-2 and Fas CD95 APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma

British journal of cancer, 2006-11, Vol.95 (9), p.1244-1249

2006

Volltextzugriff (PDF)

32P9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation

Prostate cancer and prostatic diseases, 2009-03, Vol.12 (1), p.34-40

2009

Volltextzugriff (PDF)

Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy

British journal of cancer, 2001-08, Vol.85 (4), p.557-562

2001

Volltextzugriff (PDF)

Role of IRF‐1 and caspase‐7 in IFN‐γ enhancement of Fas‐mediated apoptosis in ACHN renal cell carcinoma cells

International journal of cancer, 2003-04, Vol.104 (4), p.400-408

2003

Volltextzugriff (PDF)

Variable Bcl-2 phenotype in benign and malignant lesions of urothelium

Cancer letters, 1998-06, Vol.128 (1), p.87-92

1998

Volltextzugriff (PDF)

Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer

JNCI : Journal of the National Cancer Institute, 2004-08, Vol.96 (15), p.1161-1170

2004

Volltextzugriff (PDF)

Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes

Journal of experimental & clinical cancer research, 2000-12, Vol.19 (4), p.483

2000

Volltextzugriff (PDF)

Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients

British journal of cancer, 2001-10, Vol.85 (8), p.1119-1123

2001

Volltextzugriff (PDF)

Infrequent alteration of p53 pathway in metastatic renal cell carcinoma

Oncology reports, 1999-03, Vol.6 (2), p.329

1999

Volltextzugriff (PDF)

Prognostic Value of Bcl-2 and p53 Expression in Urinary Tract Transitional Cell Cancer

JNCI : Journal of the National Cancer Institute, 1996-05, Vol.88 (10), p.686-688

1996

Volltextzugriff (PDF)

Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC)

Anticancer research, 1998-05, Vol.18 (3A), p.1655

1998

Volltextzugriff (PDF)

Altered expression of beta-catenin and c-erbB-2 in early gastric cancer

Journal of experimental & clinical cancer research, 2000-09, Vol.19 (3), p.349

2000

Volltextzugriff (PDF)

Expression of enhancer of zeste homolog 2 in renal cell carcinoma and relationship to downregulation of micro RNA-101

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4622-4622

2010

Volltextzugriff (PDF)

Fate of patients undergoing pulmonary metastasectomy for metastatic urothelial carcinoma

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e1575-e1576

2017

Volltextzugriff (PDF)

676 ALP and bone scan flare following enzalutamide treatment of castration resistant prostate cancer (CRPC) with bone metastasis

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e676-e676

2015

Volltextzugriff (PDF)

Effect of GSK-3 inhibition in vitro and in vivo on antitumor effect of sorafenib in renal cell carcinoma (RCC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4617-4617

2010

Volltextzugriff (PDF)

652 Role of pulmonary metastasectomy in patients with metastatic urothelial carcinoma

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e652-e652

2015

Volltextzugriff (PDF)

An analysis of low miR-199a expression in renal cell carcinoma (RCC) and and its association with regulation of GSK-3beta

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15020-e15020

2011

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma

9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers

Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis

Prognostic impact of FAS CD95 APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression

2536 Treatment sequence using new antiandrogens in castration resistant prostate cancer: A retrospective study

Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients

Absence of Bcl-2 and Fas CD95 APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma

32P9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers

Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation

Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy

Role of IRF‐1 and caspase‐7 in IFN‐γ enhancement of Fas‐mediated apoptosis in ACHN renal cell carcinoma cells

Variable Bcl-2 phenotype in benign and malignant lesions of urothelium

Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer

Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes

Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients

Infrequent alteration of p53 pathway in metastatic renal cell carcinoma

Prognostic Value of Bcl-2 and p53 Expression in Urinary Tract Transitional Cell Cancer

Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC)

Altered expression of beta-catenin and c-erbB-2 in early gastric cancer

Expression of enhancer of zeste homolog 2 in renal cell carcinoma and relationship to downregulation of micro RNA-101

Fate of patients undergoing pulmonary metastasectomy for metastatic urothelial carcinoma

676 ALP and bone scan flare following enzalutamide treatment of castration resistant prostate cancer (CRPC) with bone metastasis

Effect of GSK-3 inhibition in vitro and in vivo on antitumor effect of sorafenib in renal cell carcinoma (RCC)

652 Role of pulmonary metastasectomy in patients with metastatic urothelial carcinoma

An analysis of low miR-199a expression in renal cell carcinoma (RCC) and and its association with regulation of GSK-3beta

Suchergebnisse filtern